32nd Annual Meeting of the Society for Virology, 28-31 March in Ulm, Germany
Meet our experts Dr. Alexander Birkmann, Head of Research, Dr. Peter Lischka, Senior Director Virology, and Dr. Andreas Kühbacher, Senior Manager Innovation & Alliance, at the 32nd Annual Meeting of the Society for Virology
The AiCuris Anti-infective Cures AG team is looking forward to discussing recent advancements of our pivotal phase 3 trial with Pritelivir treating immunocompromised patients with resistant HSV infections and ways to promote your own programs in the field of antiviralresearch with the AiCuris AiCubator at their posters.
PosterP064: Resistance analysis in a phase 2 clinical trial with the helicase-primase inhibitor Pritelivir in immunocompromised adults with Acyclovir resistant Herpes Simplex Virus (HSV) infection
Poster365: A novel approach to bridge the gap from virology research to new antivirals https://bit.ly/3JqQC4l